| Literature DB >> 33442290 |
Antoni Llueca1,2,3, Anna Serra1,2,3, Maria Teresa Climent1,2, Karina Maiocchi2,4, Alvaro Villarin2,4, Katty Delgado2,5, Josep Mari-Alexandre6, Juan Gilabert-Estelles6,7, Paula Carrasco3, Blanca Segarra8, Luis Gomez2,4, Juan Jose Hidalgo3, Javier Escrig3, Manuel Laguna2,4.
Abstract
BACKGROUND: Advanced ovarian cancer (AOC) requires an aggressive surgery with large visceral resections in order to achieve an optimal or complete cytoreduction and increase the patient's survival. However, the surgical aggressiveness in the treatment of AOC is not exempt from major complications, such as the gastrointestinal fistula (GIF), which stands out among others due to its high morbidity and mortality.Entities:
Keywords: advanced ovarian cancer surgery; complications; intestinal fistula; intestinal leakage
Year: 2021 PMID: 33442290 PMCID: PMC7797294 DOI: 10.2147/CMAR.S280511
Source DB: PubMed Journal: Cancer Manag Res ISSN: 1179-1322 Impact factor: 3.989
Clinicopathological Characteristics of All Patients
| Total | No | Yes | P value | |
|---|---|---|---|---|
| n=107 | n=95 (89%) | n=12 (11%) | ||
| Age | 60±10.5 | 60±10.6 | 62±10.6 | 0.52 |
| FIGO stage | 0.49 | |||
| III | 80 (74.8%) | 72 (75.8%) | 8 (66.7%) | |
| IV | 27 (25.2%) | 23 (24.2%) | 4 (33.3%) | |
| Charlson | 2±2.2 | 2±2.1 | 3±2.4 | 0.36 |
| Charlson category | 0.31 | |||
| CHR0 | 40 (37.4%) | 36 (37.9%) | 4 (33.3%) | |
| CHR1–3 | 33 (30.8%) | 31 (32.6%) | 2 (16.7%) | |
| CHR4–8 | 34 (31.8%) | 28 (29.5%) | 6 (50%) | |
| Preoperative malnutrition | 0.090 | |||
| No | 83 (77.6%) | 76 (80%) | 7 (58.3%) | |
| Yes | 24 (22.4%) | 19 (20%) | 5 (41.7%) | |
| Duration (min) of surgery | 440±163 | 434±162.8 | 490±162.2 | 0.26 |
| Operative PCI | 14±9.4 | 13±9.1 | 20±9.9 | 0.027 |
| Operative PCI category | 0.14 | |||
| 1–10 | 43 (41.7%) | 41 (45%) | 2 (16.7%) | |
| 11–20 | 35 (34.0%) | 30 (33%) | 5 (41.7%) | |
| +20 | 25 (24.3%) | 20 (22%) | 5 (41.7%) | |
| Ascitis | 0.98 | |||
| NO | 80 (74.8%) | 71 (74.7%) | 9 (75%) | |
| SI | 27 (25.2%) | 24 (25.3%) | 3 (25%) | |
| Partial bowel obstruction | 0.017 | |||
| No | 94 (87.9%) | 86 (90.5%) | 8 (66.7%) | |
| Yes | 13 (12.1%) | 9 (9.5%) | 4 (33.3%) | |
| Diffuse intestinal or mesos infiltration | 0.25 | |||
| No | 85 (79.4%) | 77 (81.1%) | 8 (66.7%) | |
| Yes | 22 (20.6%) | 18 (18.9%) | 4 (33.3%) | |
| Major invasion of wall or retroperitoneum | 0.44 | |||
| No | 96 (89.7%) | 86 (90.5%) | 10 (83.3%) | |
| Yes | 11 (10.3%) | 9 (9.5%) | 2 (16.7%) | |
| Tumor blocks or retractions | 0.42 | |||
| No | 89 (83.2%) | 80 (84.2%) | 9 (75%) | |
| Yes | 18 (16.8%) | 15 (15.8%) | 3 (25%) | |
| Diaphragmatic invasion | 0.81 | |||
| No | 96 (89.7%) | 85 (89.5%) | 11 (91.7%) | |
| Yes | 11 (10.3%) | 10 (10.5%) | 1 (8.3%) |
Principal Procedures Concerning GIF
| Total | GIF No | GIF Yes | P value | |
|---|---|---|---|---|
| N=107 | N=95 (89%) | N=12 (11%) | ||
| Peritonectomy | 0.06 | |||
| No | 24 (22.4%) | 22 (92%) | 2 (8%) | |
| Complete | 31 (29%) | 24 (77%) | 7 (23%) | |
| Partial | 52 (48.6%) | 49 (94%) | 3 (6%) | |
| Fulguration or excision of nodules | 0.39 | |||
| No | 57 (53.3%) | 52 (91%) | 5 (9%) | |
| Yes | 50 (46.7%) | 43 (86%) | 7 (14%) | |
| Visceral resection | 0.85 | |||
| No | 20 (18.7%) | 18 (90%) | 2 (10%) | |
| Yes | 87 (81.3%) | 77 (89%) | 10 (11%) | |
| Bowel resection | 0.56 | |||
| No | 25 (23.4%) | 23 (92%) | 2 (8%) | |
| Yes | 82 (76.6%) | 72 (88%) | 10 (12%) | |
| Type of bowel resection | 0.13 | |||
| No | 25 (23.4%) | 23 (92%) | 2 (8%) | |
| Rectum-Sigmoid | 15 (14.0%) | 15 (100%) | 0 | |
| Colon | 20 (18.7%) | 19 (95%) | 1 (5%) | |
| Small bowel | 22 (20.6%) | 19 (86%) | 3 (14%) | |
| Multiple | 25 (23.4%) | 19 (76%) | 6 (24%) | |
| Pancreas and/or spleen resection | 0.86 | |||
| No | 78 (72.9%) | 69 (89%) | 9 (11%) | |
| Yes | 29 (27.1%) | 26 (90%) | 3 (10%) | |
| Number of visceral resections | 4±3.1 | 3±2.8 | 6±4.1 | <0.001 |
| Grouped number of visceral resections | 0.07 | |||
| 0–2 | 44 (41.1%) | 42 (96%) | 2 (4%) | |
| >2 | 63 (58.9%) | 53 (84%) | 10 (16%) | |
| Digestive anastomosis | 0.06 | |||
| No | 45 (42.1%) | 43 (96%) | 2 (4%) | |
| Yes | 62 (57.9%) | 52 (84%) | 10 (16%) | |
| Mean digestive anastomosis per patient | 0.9±0.1 | 0.8±0.1 | 1.3±0.3 | 0.13 |
| Grouped number of digestive anastomosis per patient | 0.20 | |||
| 0–1 | 86 (80.4%) | 78 (91%) | 8 (9%) | |
| >1 | 21 (19.6%) | 17 (81%) | 4 (19%) | |
| Definitive stoma | 0.99 | |||
| No | 89 (83.2%) | 79 (89%) | 10 (11%) | |
| Yes | 18 (16.8%) | 16 (89%) | 2 (11%) | |
| Lymphadenectomy | 0.76 | |||
| No | 49 (45.8%) | 43 (88%) | 6 (12%) | |
| Yes | 58 (54.2%) | 52 (90%) | 6 (10%) | |
| Operative bleeding cc | 1926±887 | 1856±893 | 2483±611 | 0.02 |
| Grouped operative bleeding cc | 0.01 | |||
| 0–1000 | 17 (15.9%) | 17 (100%) | 0 | |
| 1000–2000 | 57 (53.3%) | 53 (93%) | 4 (7%) | |
| 2000–3000 | 24 (22.4%) | 17 (71%) | 7 (29%) | |
| +3000 | 9 (8.4%) | 8 (89%) | 1 (11%) | |
| Cytoreduction | 0.83 | |||
| Group A | 84 (78.5%) | 74 (88%) | 10 (12%) | |
| Group B | 8 (7.5%) | 7 (88%) | 1 (12%) | |
| Group C | 15 (14%) | 14 (93%) | 1 (7%) | |
| Cytoreduction | 0.54 | |||
| Group A + B | 92 (86%) | 81 (88%) | 11 (12%) | |
| Group C | 15 (14%) | 14 (93%) | 1 (7%) | |
| Length of stay | 22±20.7 | 19±14.6 | 49±38.1 | <0.001 |
| Grade CLAVIEN-DINDO | <0.001 | |||
| No complication | 50 (46.7%) | 50 (100%) | 0 | |
| I | 11 (10.3%) | 11 (100%) | 0 | |
| II | 13 (12.1%) | 13 (100%) | 0 | |
| III | 27 (25.2%) | 17 (63%) | 10 (37%) | |
| IV | 6 (5.7%) | 4 (67%) | 2 (33%) | |
| Complication grade | <0.001 | |||
| No complication | 50 (46.7%) | 52 (100%) | 0 | |
| Minor (I–II) | 24 (22.4%) | 24 (100%) | 0 | |
| Major (III–IV) | 33 (30.9%) | 19 (58%) | 12 (42%) | |
| Radiologically or endoscopically intervention | <0.001 | |||
| No | 89 (83.2%) | 84 (94%) | 5 (6%) | |
| Yes | 18 (16.8%) | 11 (61%) | 7 (39%) | |
| Surgical reintervention | <0.001 | |||
| No | 90 (84.1%) | 86 (96%) | 4 (4%) | |
| Yes | 17 (15.9%) | 9 (53%) | 8 (47%) | |
| 90 days mortality | 0.002 | |||
| No | 103 (96,3%) | 92 (91%) | 9 (9%) | |
| Yes | 4 (3,7%) | 3 (50%) | 3 (50%) | |
| Disease recurrence | 0.95 | |||
| No | 49 (45.8%) | 38 (78%) | 5 (22%) | |
| Yes | 58 (54.2%) | 51 (88%) | 7 (12%) | |
| Type of disease recurrence | 0.88 | |||
| Peritoneal | 16 (27.6%) | 14 (88%) | 2 (12%) | |
| Metastases | 31 (53.4%) | 27 (87%) | 4 (13%) | |
| Both | 11 (19%) | 9 (82%) | 2 (18%) |
The Final Model of Backward-Stepwise Logistic Regression Based on the Variables Associated with Univariate Incidence Risk of GIF
| GIF | Odds Ratio | CI 95% | p value |
|---|---|---|---|
| Operative bleeding (mL) | 1.01 | 1.001–1.022 | 0.016 |
| Partial bowel obstruction | 6.26 | 1.406–27.671 | 0.015 |
Network Weights Matrix of Correlations
| Charlson | Fistula | PCI | Bleeding | Obstruction | |
|---|---|---|---|---|---|
| Charlson | – | 0.141 | −0.067 | −0.163 | 0.137 |
| Fistula | 0.141 | – | 0.322 | 0.374 | 0.457 |
| PCI | −0.067 | 0.322 | – | 0.221 | 0.269 |
| Bleeding | −0.163 | 0.374 | 0.221 | – | −0.039 |
| Obstruction | 0.137 | 0.457 | 0.269 | −0.039 | – |
Figure 1Network paths of correlations.
Figure 2Overall survival according to the existence or absence of GIF.
Median Survival in Months in Patients with or Without GIF
| Median Survival (Months) | Median CI 95% | Hazard Ratio (GIF vs No GIF) | Hazard Ratio CI 95% | |
|---|---|---|---|---|
| GIF | 16 | 4.6–45.2 | 2.4 | 1.33–10.02 |
| No GIF | 38 | 28.6–59.8 | ||
| Global | 34 | 28.2–45.2 |
Figure 3Disease-free survival according to the existence or absence of GIF.
Figure 4Overall survival for different types of GIF.
Figure 5Disease-free survival for different types of GIF.